| Aravind Subramanian at his parents' home in Saibaba Colony, Coimbatore, in February 2026, working through HbA1c and lipid-panel reports a fortnight before submitting a parental health insurance proposal. The wrong question is which product to buy. The right question is what to disclose, and how the rules actually work after disclosure. |
The Short Version (3-Minute Read)
1. Disclosure is the foundation, not a tip. Every diagnosed condition the parent has at the time of proposal — diabetes, hypothyroidism, prediabetes, borderline cholesterol, an old knee fracture — must go on the proposal form, regardless of whether medication is being taken or how recently it was diagnosed. Senior-age proposals almost always trigger a Pre-Policy Medical Check-up under the IRDAI Master Circular on Health Insurance Business dated 29 May 2024 (IRDAI/HLT/CIR/PRO/84/5/2024); the conditions show up in fresh blood tests anyway. Selectively withholding is the single biggest reason senior claims get rejected later.
2. The 36-month PED waiting period is the new ceiling, and the 60-month moratorium is the real protection. The IRDAI (Insurance Products) Regulations, 2024, effective 1 April 2024, capped the maximum pre-existing-disease waiting period at 36 months and the moratorium at 60 months of continuous coverage. After 60 months, an insurer cannot deny a claim on grounds of non-disclosure or misrepresentation, except for established fraud. This is the most important consumer protection in Indian health insurance and is barely discussed in product comparisons.
3. PED-reduction riders matter, but only for declared conditions, and the way they expire is widely misunderstood. Care Supreme's PED Wait Period Modification add-on cuts the wait to one or two years for declared PEDs. HDFC Ergo Optima Secure's ABCD Chronic Care rider cuts the wait to 30 days for asthma, blood pressure, cholesterol and diabetes only — hypothyroidism is not covered under ABCD. New diagnoses that genuinely arise after the policy starts are not subject to the PED waiting period at all, regardless of whether the rider is in force or has been removed; many advisors get this wrong.
4. Brand reputation is the wrong filter. IRDAI numbers are the right filter. The IRDAI Annual Report FY 2024-25 puts the Standalone Health Insurer industry claim-settlement ratio at 64.71% and the SAHI Incurred Claims Ratio at 68.06%. Health-claim repudiations totalled around Rs 30,000 crore in FY 2024-25, up about 15% over the prior year. On 15 December 2025 IRDAI imposed a Rs 1 crore penalty on Care Health Insurance for cashless-claim-settlement lapses. Star Health drew the highest absolute Insurance Ombudsman complaint volume in FY 2023-24 at 13,308 complaints. None of this shows up in brand surveys; all of it shows up in the Annual Report and the Council for Insurance Ombudsmen reports.
5. Network hospital reach in your specific area matters more than national rankings. When a 60-year-old parent needs admission, the difference between cashless at a hospital five kilometres away and reimbursement at a non-network hospital is fronting two to ten lakh rupees during the medical event and waiting sixty to ninety days for repayment. HDFC Ergo lists a cashless network of around 16,000 providers, Care Health discloses tie-ups of 25,000-plus including preferred-provider arrangements, but the only number that matters is the one in your parents' pin code. Verify before you sign, not after.
The full walkthrough — Section 45 of the Insurance Act 1938 versus the IRDAI moratorium, the Mahakali Sujatha Supreme Court judgment of April 2024, the rider mechanics with worked examples, the Care Supreme versus HDFC Ergo Optima Secure comparison for parental PEDs, the IRDAI claim-data sources, the 30-day free-look window strategy, the Section 80D tax math, six real worked scenarios, the rejection-reasons matrix, and the practical buying process.
By Dinesh Kumar S · Published February 04, 2026 · 26 min read
Last verified against the IRDAI Master Circular on Health Insurance Business IRDAI/HLT/CIR/PRO/84/5/2024 dated 29 May 2024, the IRDAI (Insurance Products) Regulations 2024 effective 1 April 2024, the IRDAI Master Circular on Protection of Policyholders' Interests 2024, the IRDAI senior-citizen premium cap circular dated 30 January 2025, the IRDAI Annual Report 2023-24 published December 2024, the IRDAI Annual Report 2024-25 highlights as released through PIB late 2025, the Council for Insurance Ombudsmen Annual Report 2023-24, the Care Supreme product wording (UIN CHIHLIP23128V012223), the HDFC Ergo Optima Secure policy wording (UIN HDFHLIP23123V022223), the Mahakali Sujatha versus Future Generali Supreme Court judgment (2024 INSC 296) of 10 April 2024, Section 45 of the Insurance Act 1938 as amended in 2014, and Section 80D of the Income-tax Act 1961 as applicable for FY 2025-26, on April 24 2026.
Aravind Subramanian is a software product manager in his early thirties who lives in Bellandur, Bangalore. His parents, Subramanian Krishnaswamy and Vasundhara, live in Saibaba Colony in Coimbatore. The father is fifty-eight, retired four years ago as a Senior Manager at the Coimbatore main branch of Indian Bank, and was diagnosed with Type 2 diabetes in his early fifties. He is on metformin, walks an hour every morning at the V.O.C. Park nearby, and his last HbA1c reading was 7.1. He was diagnosed with hypothyroidism in 2022 and takes levothyroxine 50 mcg every morning. His lipid panel from January 2026 shows borderline LDL of 138 mg/dL, with no statin prescribed yet. The mother is fifty-two, teaches Class 9 mathematics at a Coimbatore CBSE school, fractured her right knee in a road accident in late 2014 and had open reduction with internal fixation at G. Kuppuswamy Naidu Memorial Hospital. The plates were never removed. Her January 2026 fasting blood-sugar reading came back at 109 mg/dL with HbA1c 5.99, which puts her in the prediabetic band, and her LDL is 142 mg/dL.
What pushed Aravind to actually start the parental health insurance conversation in February 2026 was the death of his father's college friend two months earlier, a retired LIC agent in Erode, who had a heart attack at sixty-one and whose family discovered, two days into the ICU bill, that the cashless authorisation on his Star Health policy was being withheld pending a non-disclosure investigation. The hospital had asked the family to deposit Rs 4.5 lakh as a continuation guarantee. The widow eventually paid the bill from a fixed deposit and recovered most of it nine months later through the Insurance Ombudsman, but the experience of standing at the cashier's counter at midnight with a husband on a ventilator was one Aravind's father retold to Aravind several times in those weeks. That conversation is what triggered the Care Supreme brochure download, the Ditto Insurance call, the lipid-panel diagnostics in the corner clinic on Mettupalayam Road, and the steel almirah of paper that this article exists to walk through.
This is the long answer to the question Aravind sent me, expanded into a piece for any adult Indian child buying parental health insurance in 2026 where one or both parents have pre-existing conditions. The audience I have in mind is the thirty-four-year-old IT worker in Whitefield whose mother in Madurai has just been put on glimepiride, the chartered accountant in Pune whose father in Lucknow is on amlodipine for hypertension, the consultant in Hyderabad whose parents in Vellore both have borderline lipid panels and a family history of cardiac events. The decision hierarchy that I keep arriving at after reading the IRDAI circulars, sitting through the policy wordings, and watching real claims play out is the inverse of the one almost every Indian finance blog presents. Brand and price come last. Disclosure and claim mechanics come first. The article that follows builds out that hierarchy, with the regulatory and case-law machinery underneath it, and the worked scenarios at the end.
In This Article
▸ The Decision Hierarchy Most Articles Get Backwards
▸ Disclosure Is the Foundation Everything Else Sits On
▸ Section 45, the IRDAI Moratorium, and Why the Three-Year Number Misleads
▸ How PED Waiting Periods Actually Work in 2026
▸ PED Reduction Riders — What They Buy and What They Do Not
▸ Care Supreme Versus HDFC Optima Secure for Parents with Multiple PEDs
▸ Choosing an Insurer from IRDAI Numbers, Not Brand Reputation
▸ Network Hospital Reach in Your Specific Pin Code
▸ The 30-Day Free Look Window Is Your Last Defence
▸ Tax Treatment Under Section 80D for FY 2025-26
▸ Six Real Scenarios Mapped to the Right Decision
▸ Common Rejection Reasons Across Parental Senior Claims
▸ How to Actually Buy — The Process
▸ Frequently Asked Questions
The Decision Hierarchy Most Articles Get Backwards
Open any of the top ten Indian finance blogs on parental health insurance and the structure is almost identical. Brand reputation in the introduction. Sum-insured selection in the next section. Premium comparison in a table. Some discussion of co-pay and room rent. A passing mention of PED waiting periods. A footnote about disclosure, usually buried under the heading Other Things to Keep in Mind. The implied hierarchy is brand, then features, then PED rules, then disclosure as a procedural detail at the end.
This is upside down. The hierarchy that produces good outcomes for parents with pre-existing conditions runs in the opposite direction. Disclosure first, because non-disclosure is the single most common reason senior claims get repudiated. Claim mechanics second, because the IRDAI claim-settlement ratio, the complaint-per-policy number and the cashless-authorisation timeline determine whether the claim that does get filed actually gets paid. Coverage features third, because room-rent capping and disease sub-limits and consumables coverage matter, but only after the first two are settled. Pricing last, because a Rs 35,000 premium difference is a rounding error against a Rs 18 lakh claim repudiation.
The reason almost every blog inverts this is that disclosure does not generate affiliate revenue. A premium-comparison table does. A claim-settlement chart does not move policy sales the way a side-by-side rider grid does. The Indian finance blog economy, with its referral-fee structures and its lead-generation metrics, has a structural pull toward the inverted hierarchy. None of which makes the inverted hierarchy correct. It just makes it ubiquitous.
Aravind's first instinct, when he sat down with the Care Supreme brochure on a Sunday afternoon in Saibaba Colony, was to compare premiums and look for which plan covered the most consumables. He spent forty minutes on that. Then he spent four hours over the following week on the disclosure question. By the end of that week he understood why the four hours mattered more than the forty minutes. The article from here is built in that order.
Already comfortable with disclosure rules? If you understand how PED declaration works and want to start comparing specific insurers and plans for your parents, jump to the plan-by-plan comparison: which insurers above 60 actually accept pre-existing conditions → with realistic premium ranges.
Disclosure Is the Foundation Everything Else Sits On
The proposal form for any health insurance policy in India runs to about twelve to fifteen pages and contains, in the medical-history section, between forty and seventy questions. Most are routine. A few are decisive. The questions about diagnosed conditions, medication being taken, hospitalisations in the past five years, and family history of specific illnesses are the ones that, when answered carelessly, void the policy.
The doctrine that governs this section is uberrimae fidei, utmost good faith, the highest standard of honesty in contract law. Insurance contracts are uberrimae fidei because the proposer has all the relevant information about their own health and the insurer has none. The bargain the proposer makes when they sign the form is that they have disclosed every material fact that could affect the underwriter's decision, whether or not the question explicitly asked about that specific fact. The Supreme Court reaffirmed this most recently in Mahakali Sujatha versus Future Generali India Life Insurance Company, Civil Appeal No. 3821 of 2024, judgment dated 10 April 2024, where the bench of Justices B.V. Nagarathna and Augustine George Masih held that the burden of proving fraudulent non-disclosure rests entirely on the insurer, and that mere assertions or unauthenticated tabulations are insufficient. That judgment is on a life insurance contract but the principle, that the duty of good faith is symmetrical, is now routinely applied by district forums and ombudsmen to mediclaim disputes.
The most common selective disclosures, in my own correspondence and in the Insurance Ombudsman reports for the past three years, fall into a small set of patterns. The proposer says yes to diabetes but no to hypertension because they think hypertension is just a number that goes up and down. They mention the diabetes medication but not the levothyroxine for hypothyroidism because they think thyroid is not a disease. They mention current conditions but not a knee surgery done in 2014 because they think anything older than ten years has expired in some sense. They list their own father's condition as no family history because they read the question to mean only living parents. Each of these is a non-disclosure that, in the right insurer's hands at the wrong moment, voids the policy.
What the insurer does with disclosed conditions is rarely what the proposer fears. For Aravind's father's profile, with controlled diabetes, hypothyroidism on a stable dose of levothyroxine, and borderline cholesterol with no statin, the underwriting outcomes I have seen across Care Health and HDFC Ergo and Niva Bupa proposals fall into one of three categories. Acceptance at standard premium with all three conditions added to the declared PED list. Acceptance with a small loading of around five to ten percent on the base premium. Acceptance with a permanent exclusion on one of the conditions, almost always the diabetes, with the other two on the standard PED waiting period. Outright decline is rare for this profile. The terror of disclosure is overwhelmingly disproportionate to the actual underwriting consequence.
What the insurer does with non-disclosed conditions is the entire risk. The Pre-Policy Medical Check-up under the IRDAI Master Circular on Health Insurance Business dated 29 May 2024, reference IRDAI/HLT/CIR/PRO/84/5/2024, requires insurers to bear at least fifty percent of the cost of the examination if the proposal is accepted at standard or sub-standard rates. The PPMC for senior parental proposals almost always includes a CBC, fasting blood glucose, HbA1c, lipid profile, urea, creatinine, urine routine and ECG. A 7.1 HbA1c walks into that test panel with a flashlight. A 5.99 HbA1c does too. The conditions that Aravind's parents have are conditions that the underwriter is going to learn about within forty-eight hours of the blood-draw appointment. The only question the proposer controls is whether the insurer learns about them from the proposal form or from the test reports. When those two sources contradict each other, the policy is voidable from inception under the proposal-form attestation, and any claim filed later runs straight into a non-disclosure repudiation.
The single piece of practical advice that I now give every adult child filling out a parental proposal form is this. List every diagnosis on a single A4 sheet before you start the form. Diagnosis date, current medication, dosage, last test result with date. Then transcribe that sheet into the form. Then upload the underlying lab reports as supporting documents at the end. Underwriters reading complete disclosures with documentation routinely accept the proposal in days. Underwriters reading partial disclosures with red-flagged PPMC findings spend weeks asking for additional information and often issue a counter-offer with exclusions. The faster, cheaper path is the more honest one. This is the rare case where the careful and the lazy answer converge.
Section 45, the IRDAI Moratorium, and Why the Three-Year Number Misleads
The phrase that floats around Indian personal-finance discussions whenever non-disclosure comes up is the three-year rule, attributed to Section 45 of the Insurance Act 1938. The shorthand version goes something like this. After three years from the policy issue date, the insurer cannot question the policy on any ground, including non-disclosure, so as long as you make it past three years you are protected. This shorthand is half-right and half-misleading, and the half that misleads is the half that matters.
Section 45, as amended in 2014, applies in its express text to life insurance policies. The post-2014 wording reads that no policy of life insurance shall be called in question on any ground whatsoever after the expiry of three years from the date of the policy or the date of revival or the date of the rider, whichever is later. Two things follow. First, mediclaim policies are not, on the face of the statute, governed by Section 45. The Supreme Court has held this directly in Satwant Kaur Sandhu versus New India Assurance Company (2009) 8 SCC 316 and reiterated it in subsequent decisions. The duty of utmost good faith still applies to a mediclaim contract, but the three-year incontestability backstop in the statute does not.
The actual protection for mediclaim policyholders is the moratorium clause introduced through the IRDAI Master Circular on Health Insurance Business dated 29 May 2024, which reduced the moratorium period from the earlier ninety-six months to sixty months of continuous coverage. After sixty months, an insurer cannot deny a claim on grounds of non-disclosure or misrepresentation, except where established fraud is proven. Continuous coverage includes credits accrued under ported and migrated policies, so a policyholder who switches insurers without a gap continues to build moratorium credit on the new insurer's books from the original start date.
The practical implications of this distinction are significant. A senior parent who buys a Care Supreme policy in May 2026 reaches the moratorium milestone in May 2031, not May 2029. Claims filed in years two, three and four are still vulnerable to non-disclosure-based repudiation if the insurer can establish that a material fact was suppressed at proposal stage. Only in year six does the protection become near-absolute. The three-year shorthand, applied to mediclaim, gives a false sense of security in years three through five, which is precisely the period when senior policyholders are most likely to make their first significant claim.
The other piece worth knowing, particularly for senior policyholders, is the burden of proof. Within the moratorium period, an insurer alleging non-disclosure must prove three things, per the Mahakali Sujatha bench. First, that the fact in question was material to the underwriter's decision. Second, that the proposer had knowledge of the fact at proposal stage. Third, that the suppression was fraudulent rather than merely careless. Mere assertion is not enough. Internal medical-records summaries are not enough. Unauthenticated photocopies of prior consultations are not enough. The insurer must produce primary documentary evidence, properly attested, and must show that the proposer either knew the fact or could reasonably have been expected to know it. This is a meaningful shield, and it applies to mediclaim contracts by analogy. It does not, however, replace the simple discipline of full disclosure at proposal stage. The shield is for the proposer who disclosed and was repudiated anyway. It is not for the proposer who selectively withheld.
How PED Waiting Periods Actually Work in 2026
Three distinct waiting periods sit inside every Indian health insurance policy. They get conflated in conversation routinely. They are not the same thing and they do not interact the way readers usually assume.
The first is the initial waiting period. Thirty days from policy commencement, during which no claim is admissible except for accidental injury. This is universal across every insurer in India and is now codified in the 2024 IRDAI master circular. It exists to prevent same-day adverse selection.
The second is the specific-illness waiting period. Twenty-four months by default in most policies, applicable to a list of named conditions that the insurer treats as predictably elective or chronic. Cataract, hernia, fissures and fistulas, knee replacement, hip replacement, cholecystectomy for gallstones, hysterectomy for benign conditions, varicose veins, sinusitis, deviated nasal septum, kidney stones, and a few others. This list applies regardless of whether the condition existed at proposal or developed after. It is a feature of the base policy, not a feature of the proposer's medical history. The IRDAI 2024 reforms capped the maximum specific-illness waiting period at thirty-six months but most insurers stayed at twenty-four.
The third is the PED waiting period, which is the one almost every conversation about parental insurance is actually about. The IRDAI (Insurance Products) Regulations 2024, gazetted in March 2024 and effective 1 April 2024, made two simultaneous changes. The PED definition was tightened to a thirty-six-month look-back window, meaning a condition is pre-existing only if it was diagnosed within thirty-six months prior to policy commencement, or if advice or treatment was received in that window. And the maximum allowable PED waiting period was capped at thirty-six months, down from the earlier forty-eight. So a condition that was diagnosed forty months before policy commencement is, by IRDAI's current definition, no longer a PED at all. A condition diagnosed within the last thirty-six months is a PED, with a maximum of thirty-six months of waiting before it gets covered.
The conceptual error that almost every reader makes is to treat any chronic condition diagnosed at any point in the parent's life as a PED. Aravind's father's hypothyroidism was diagnosed in 2022, four years before the proposal. Strictly under the 2024 definition, this is not a PED at all because the diagnosis falls outside the thirty-six-month look-back window. The diabetes, diagnosed in 2017, is also outside the window. In practice, insurers continue to ask about these conditions on the proposal form and may load or exclude them, because the underwriting question of risk is broader than the regulatory question of PED status. But the technical PED definition is narrower than the typical conversational sense of pre-existing.
The other conceptual error, and this is the one I corrected myself on publicly in February when a Reddit user pushed back on a careless reply, is the assumption that any diagnosis discovered during the policy term is a PED. It is not. A condition that genuinely arises after policy commencement, that did not exist at proposal stage, is not a PED. It is a fresh diagnosis. It is subject only to the initial thirty-day waiting period and any specific-illness waiting if the condition is on that list. The PED waiting period does not apply to it. The underwriter cannot, in the absence of evidence of pre-existence, retrospectively classify a year-three diagnosis as a PED. This matters enormously for the rider question that the next section deals with, and it is also the answer to one of the most common Reddit questions in Indian personal finance, about whether dropping a PED reduction rider in year four exposes the parent to fresh waiting periods on new diagnoses. It does not.
PED Reduction Riders — What They Buy and What They Do Not
The two riders that come up most often in parental health insurance conversations in 2026 are Care Supreme's PED Wait Period Modification and HDFC Ergo Optima Secure's ABCD Chronic Care. They do superficially similar things, but the mechanics are different and the misconceptions that surround them are also different.
Care Supreme's PED Wait Period Modification is an optional add-on that reduces the thirty-six-month standard PED waiting period to either twelve or twenty-four months, depending on the variant chosen. It applies to all PEDs declared at proposal stage, not to a specific list. The premium loading varies by age and sum insured, but for Aravind's parents at fifty-eight and fifty-two, with the conditions declared, the additional premium for the one-year modification on a Rs 25 lakh sum insured worked out to roughly twelve to fifteen percent of the base premium. The brochure I located on careinsurance.com is explicit that the Modification is mutually exclusive with Care Supreme's other PED-related add-on, the Instant Cover. A proposer can opt for one or the other, not both.
Care Supreme's Instant Cover add-on takes a different approach. It reduces the PED waiting period to thirty days, but only for four specific conditions: diabetes, hypertension, hyperlipidemia and asthma. These four are the same conditions that the HDFC ABCD rider covers. Both add-ons require the conditions to be declared at proposal stage to be eligible for the reduction. Neither covers hypothyroidism, which is the gap that Aravind's father walks into.
HDFC Ergo's ABCD Chronic Care rider, as the name spells out, covers asthma, blood pressure, cholesterol and diabetes Type 2. The reduction is to a thirty-day waiting period from policy start. The rider is structured as an annual add-on attached to the base Optima Secure policy. Online reviews and broker pages variously describe it as non-removable for life once opted, but the policy wording I located does not contain an explicit lock-in clause to that effect. What the wording does say is that riders are added at policy inception or renewal, and that removal would require a fresh underwriting decision at the next renewal. The functional effect is similar to a lock-in for chronic-condition holders, since once the parent is past the initial thirty-day window and starts claiming for diabetes treatment, removing the rider exposes them to the standard thirty-six-month PED waiting period on subsequent diabetes claims if the rider is dropped. Removability is, to my reading, a more nuanced question than the broker shorthand admits.
The most important thing both riders share, and that almost no comparison article mentions, is what they do not cover. The PED waiting period applies, by definition, to pre-existing diseases declared at proposal. A new diagnosis of, for example, cardiac arrhythmia in policy year three is not a PED. It is a fresh diagnosis. The PED reduction rider is irrelevant to it. The new condition is covered after the standard initial thirty-day waiting period, regardless of whether the rider is in force. So the cost-benefit calculation of keeping the rider after year three is narrower than most readers think. By the end of year three, all originally declared PEDs would have completed their thirty-six-month waiting period under the base policy anyway. The rider's continuing benefit, after year three, is essentially zero for the originally declared conditions and zero for new conditions that were not pre-existing. Whether to retain the rider after year three is genuinely a question of whether the rider's premium is worth the buffer against the small subset of cases where a condition turns out to have been pre-existing in the strict thirty-six-month sense but was not detected at PPMC.
The honest read for Aravind's family is that the Care Supreme PED Wait Period Modification at the one-year option is a meaningful purchase for the first three years of the policy. After that, the practical decision to drop or keep the rider becomes a much smaller question than the marketing materials make it sound. The rider expires into irrelevance, in most parent profiles, around the fourth renewal.
| The two products at a glance, for the parental PED profile most readers are actually buying for. The hypothyroidism gap on HDFC's ABCD rider is the most decision-relevant difference for families like Aravind's. The IRDAI 60-month moratorium applies equally to both. |
Care Supreme Versus HDFC Optima Secure for Parents with Multiple PEDs
The Care Supreme versus HDFC Optima Secure question is the one that turns up most often in chats and DMs through the first quarter of 2026, and the right answer for the multi-PED parent profile is not the answer the brand-driven comparisons usually arrive at.
For Aravind's father, with diabetes plus hypothyroidism plus borderline cholesterol, the structural difference between the two products is the hypothyroidism gap. HDFC's ABCD Chronic Care rider, by its acronym, covers four conditions. Asthma. Blood pressure. Cholesterol. Diabetes. Hypothyroidism is not on the list and is not covered under any other thirty-day reduction. The standard thirty-six-month PED waiting period applies to it. For Aravind's father, this means three years of out-of-pocket spending on any thyroid-related complication, including any thyroid surgery if a nodule develops, and any cardiac complication that the insurer can argue was thyroid-related. Care Supreme, by contrast, has the PED Wait Period Modification add-on at one or two years, which applies to all declared PEDs including hypothyroidism. The one-year reduction option costs additional premium but covers the gap.
For the mother's profile, with prediabetes and borderline cholesterol, both products perform similarly. Care Supreme's Instant Cover and HDFC's ABCD both reduce the waiting period to thirty days for diabetes and cholesterol. Prediabetes is not technically diabetes yet, so the underwriter's classification matters, but in either product the path to coverage is short.
The room-rent capping question, which dominates a lot of comparison articles, is largely settled in both products. Care Supreme imposes no room-rent cap and no disease sub-limits. HDFC Optima Secure also imposes no room-rent cap and no disease sub-limits. The base policy structures are functionally similar on this point. The Restore and No Claim Bonus features differ in implementation but converge in effect for most claim patterns: both products grow the sum insured over time without claim, and both restore the sum insured during the policy year if exhausted.
The IRDAI claim-data gap between the two insurers, which I will discuss in detail in the next section, is significant and tilts in HDFC's favour for FY 2024-25. Network hospital reach varies by city and is the question that should be answered last, with the actual pin code of the parent in hand, not from a national headline number.
The honest verdict, for the multi-PED parent profile that matches Aravind's father, is that Care Supreme with the PED Wait Period Modification rider at the one-year variant is the cleaner fit for the diagnosed-condition coverage. HDFC Optima Secure with the ABCD rider, given the hypothyroidism gap, sits one notch lower for that specific medical profile, even though it has stronger IRDAI claim metrics. The right buyer's question is which gap matters more in your case, and the answer turns on which conditions are on the parent's diagnosis list. That is a different question from which insurer has the bigger brand.
Choosing an Insurer from IRDAI Numbers, Not Brand Reputation
Three numbers from the IRDAI Annual Report and the Council for Insurance Ombudsmen Annual Report should drive the insurer selection. The Claim Settlement Ratio. The Incurred Claims Ratio. The complaint count and complaint-per-policy ratio. None of these match the brand-survey numbers that show up in newspaper roundups, and the gap between the two sources is, in itself, instructive.
The Claim Settlement Ratio, on a number basis, is the percentage of claims received that the insurer settled in the relevant financial year. For FY 2024-25, on Ditto's standardised formula drawn from IRDAI's NL-37 and NL-39 public disclosures, HDFC Ergo settled 97.45 percent of claims, with a three-year average of 96.71. Care Health settled 96.74 percent of claims, with a three-year average of 93.13. Star Health, the largest standalone health insurer by retail share, settled 99.06 percent. Niva Bupa settled 92.39 percent. The industry average for the Standalone Health Insurer category, per the IRDAI Annual Report 2023-24, was 64.71 percent on a number basis, which sounds startlingly low until one realises it includes a large volume of intimated-but-not-completed claims; the on-an-amount basis figures are higher.
The Incurred Claims Ratio measures the share of premium that the insurer pays out as claims. The IRDAI Annual Report 2024-25 puts the SAHI category combined ICR at 68.06 percent, which is rising, and the public-sector general insurer ICR at 99.84 percent, which has historically been close to or above one hundred percent. HDFC Ergo's health ICR for FY 2023-24 stood at 89.47 percent, which is on the higher end and signals underwriting stress as well as more generous claim payouts. Care Health's ICR has run in the sixty to sixty-five percent band, which is more profitable for the insurer and slightly more conservative on claims. Neither number is good or bad in isolation. A very low ICR can indicate underclaim payment. A very high one can indicate poor risk selection. The pattern over three to five years matters more than any single year.
The complaint data is where the insurer-level differences become decision-relevant. The Council for Insurance Ombudsmen Annual Report 2023-24, which Outlook Money and Business Standard summarised in early 2025, recorded 13,308 complaints against Star Health, the highest absolute volume in the industry, of which 10,196 were partial or full claim repudiations under Rule 13(1)(b) of the Insurance Ombudsman Rules 2017. The Ombudsman ordered Star Health to pay over Rs 6,000 crore in awards in that year. Care Health drew 3,718 complaints with 2,393 in the same Rule 13(1)(b) bucket; awards totalled Rs 2,012 crore. Niva Bupa drew 2,511 complaints, with awards of Rs 1,654 crore. HDFC Ergo drew Rs 648 crore in awards. On a complaint-per-lakh-policyholders basis, Star Health stood at 63 per lakh, Niva Bupa at 17, and Care Health at 16. The dispersion across insurers is not narrow.
The other piece of recent evidence that deserves a mention is the IRDAI order dated 15 December 2025 imposing a Rs 1 crore monetary penalty on Care Health Insurance for serious lapses in cashless claim settlement, including only 31 percent of sampled claims having the required discharge-summary signatures, undisclosed tariff deductions, inadequate communication of Insurance Ombudsman details in repudiation letters, and Rs 1.06 crore in unallocated proposal deposits not transferred to the unclaimed-amounts account. The penalty must be paid from shareholders' funds, with an Action Taken Report to the board within ninety days. This does not make Care a bad insurer. It does mean that the FY 2024-25 claim-settlement-ratio number, taken alone, undersells the operational issues. Aggregate ratios and regulatory orders both belong in the decision.
The right way to use this data is not to pick the highest ratio. It is to verify, in the latest IRDAI Annual Report and the latest CIO Annual Report, that the insurer you are considering sits in the upper half of its peer group on claim settlement, in the lower half on complaint volume per policy, and has not been the subject of an IRDAI penalty in the past eighteen months. The Annual Reports are public. They are at irdai.gov.in. Most readers never open them, which is one of the larger informational asymmetries in Indian retail finance.
Network Hospital Reach in Your Specific Pin Code
Brand-level network counts are noise. The number that determines the actual cashless experience is the count of network hospitals within fifteen kilometres of the parent's home. A parent in Saibaba Colony, Coimbatore, who needs admission at midnight is going to one of three or four hospitals nearby. PSG Hospital. Kovai Medical Center and Hospital. KMCH Speciality Hospital. G. Kuppuswamy Naidu Memorial Hospital. The relevant question is whether all four are in the insurer's cashless network. The fact that the insurer has 11,000 or 16,000 cashless hospitals across India is not the question.
The verification process is twenty minutes of work and almost nobody does it. Both Care Health and HDFC Ergo publish hospital-locator tools on their websites with pincode and city filters. The tool returns the list of network hospitals within the chosen radius. Cross-check this against the actual hospitals where the parent's primary physician practises, the hospital where the parent's chronic-condition specialist is based, and the two largest hospitals nearest the home. If three of those four are in network, the cashless experience will probably be smooth. If none or only one is in network, the policy will be operating mostly through reimbursement, which means the family pays the bill and waits sixty to ninety days for the insurer to repay.
The reimbursement experience matters more for senior parents than for working-age policyholders, for two practical reasons. The first is the size of senior hospitalisation bills. A bypass surgery in a Tier-1 city in 2026 costs three to six lakh rupees upfront. An ICU stay for a respiratory infection runs to four to eight lakh rupees over a week. Cancer treatment runs from twelve lakh upwards. Asking a retired parent to front this kind of money on a credit card or a fixed-deposit break, and then waiting two to three months for repayment, is not a small ask. The second is the operational stress of the medical event itself. The family is already managing a sick parent. The last thing the family should be doing is haggling with a hospital cashier at midnight. Cashless removes that whole layer of stress. The cashless network reach in your specific area is therefore worth more than a marginal premium difference, and it is the one feature that does not show up in any premium-comparison table.
The question to send to Ditto or Beshak before you sign anything is precise: list the Care Health and HDFC Ergo cashless network hospitals within ten kilometres of pin code 641011 (or whichever pin code the parents live in), and flag whether the parent's existing physician hospital is in network. They will pull the answer in five minutes from the same tool you can use yourself.
The 30-Day Free Look Window Is Your Last Defence
The IRDAI extended the free look period from fifteen days to thirty days through a circular dated 20 March 2024, applicable to all life and health insurance policies issued on or after 1 April 2024 with a tenure of one year or more, regardless of distribution mode. The thirty-day window starts on the date the policyholder receives the policy document, not the date the premium was paid. During this window, the policyholder can return the policy for any reason, with or without explanation, and recover the entire premium minus a small deduction for stamp duty, medical-examination cost where applicable, and proportionate risk premium for the days the cover was in force. The right to return is statutory, not insurer-discretionary.
The reason this window matters more than most readers realise is that the proposal form, the brochure, the quote, and the actual policy document do not always say the same thing. The brochure says the PED waiting period is one year with the rider. The actual policy schedule, when it arrives, says two years. The brochure mentions hypothyroidism in passing under chronic conditions. The actual policy schedule includes a permanent exclusion on hypothyroidism that the underwriter added during processing without telling the proposer. These mismatches are common, and they are recoverable only inside the thirty-day window. Once the window closes, returning the policy means forfeiting most of the premium.
The thirty-day discipline that I now recommend to every reader buying parental health insurance is fixed. Day one, when the policy document arrives by email, open it within twenty-four hours. Day two through five, read the schedule of benefits, the schedule of exclusions, and the rider terms in full. Day six, write a single A4 sheet listing every promise made at proposal stage by the agent or aggregator: PED waiting period, rider mechanics, room rent rules, sub-limits, network hospital count, claim settlement promises. Day seven through ten, cross-check each promise against the actual policy document. Day fifteen, if there is any mismatch, send the insurer a written email asking for clarification or correction. Day twenty, if the response is unsatisfactory, file a free-look return. Day twenty-five, the refund should be processed. Day thirty, the window closes.
The three discrepancies that most often show up in this exercise, for senior parental policies, are an exclusion on a declared condition that was not disclosed in the proposal acceptance letter, a higher PED waiting period than the rider was meant to deliver, and a co-payment clause attached to the senior-age band that was not mentioned in the quote. Each of these is reversible inside the window. Each is functionally permanent outside it. The thirty days are not a courtesy. They are the consumer's last actual control point.
| The four phases of the disclosure-protection clock. The most under-discussed protection in Indian health insurance sits on the right edge of this bar. Sixty months of continuous coverage and the insurer can no longer challenge the policy on non-disclosure grounds, except where established fraud is proven. |
Tax Treatment Under Section 80D for FY 2025-26
Section 80D of the Income-tax Act 1961 is the deduction provision that almost every Indian salaried earner has heard of and almost none has used to its full extent. For FY 2025-26, the limits matter for parents with PEDs because the senior-citizen-parent component is the single largest 80D bucket available to most filers. The limits for the assessment year 2026-27, applicable to income earned in FY 2025-26, are unchanged from prior years.
The taxpayer's own family component, covering self, spouse and dependent children where everyone is below sixty, is up to Rs 25,000 per annum. The parent component, where parents are below sixty, is an additional Rs 25,000. The parent component, where one or both parents are senior citizens at sixty or above, is an additional Rs 50,000. The aggregate cap, where the taxpayer is below sixty and the parents are senior citizens, is Rs 75,000. Where both the taxpayer and the parents are sixty-plus, the cap is Rs 1,00,000. A preventive health check-up sub-limit of Rs 5,000 sits inside the overall cap and is the only sub-component that can be paid in cash; everything else must be in cheque, NEFT, RTGS, UPI, debit card, credit card or net banking to qualify for the deduction.
Two procedural details matter. The first is that Section 80D applies under the old tax regime only. The new regime under Section 115BAC, which has been the default since 1 April 2024, does not allow the 80D deduction. A senior parent's premium of Rs 50,000 saves a thirty-percent-bracket taxpayer Rs 15,000 in tax under the old regime and zero under the new regime. The choice of regime materially changes the after-tax cost of the parental health insurance purchase. The second is that, for senior parents, where no health insurance policy is in force, the taxpayer can claim medical expenditure actually incurred up to Rs 50,000 as a deduction within the parent component. This is useful for parents who are uninsurable due to chronic conditions or who declined to take a policy. The expenditure must be in non-cash mode and must be for the senior-resident parent.
The AY 2025-26 ITR forms now require the taxpayer to enter the insurer name and the policy number in Schedule 80D. Generic claims without policy numbers are flagged for verification. The discipline of keeping policy documents and premium receipts in a single labelled folder, both for self and parents, is no longer optional from a tax compliance standpoint.
Six Real Scenarios Mapped to the Right Decision
The abstract rules become tractable when placed against actual people. The six scenarios that follow are drawn from reader correspondence, Insurance Ombudsman case patterns, and DM threads through the second half of 2025 and the first quarter of 2026. Names and a few small specifics have been changed.
Scenario one. Aravind Subramanian's parents, Coimbatore, March 2026. Father fifty-eight with diabetes plus hypothyroidism plus borderline cholesterol; mother fifty-two with prediabetes plus borderline cholesterol plus a 2014 knee fracture with retained hardware. Multi-individual Care Supreme policy at Rs 25 lakh sum insured each, with PED Wait Period Modification rider at the one-year variant, and the Cumulative Bonus Super add-on declined for the first year and reconsidered at first renewal. Premium worked out to roughly Rs 78,000 for the two parents combined for FY 2025-26, of which Rs 50,000 is deductible under the parent-component of Section 80D. All four PEDs declared at proposal. PPMC done at the empanelled Care lab in R.S. Puram. Underwriter accepted at standard premium with a small loading of seven percent for the father's profile. No exclusions issued. The Care Supreme PED Wait Period Modification covers all declared PEDs from year two onwards. By the end of year three the standard thirty-six-month PED waiting period would have lapsed for everything anyway, and the rider becomes informational rather than substantive.
Scenario two. Lakshmi Padmanabhan, IT consultant in Whitefield, mother in Madurai, April 2026. Mother sixty-one, recently diagnosed with Type 2 diabetes, on glimepiride plus metformin, no other conditions. Lakshmi considers Star Health Senior Citizen Red Carpet and Care Senior Health Advantage, both senior-specific products with mandatory twenty-percent co-payment. Both have higher entry-age premiums but the Senior Citizen Red Carpet has a mandatory two-year PED waiting period. Lakshmi reviews the FY 2023-24 Insurance Ombudsman complaint data showing Star Health with the highest complaint volume in the industry and decides against Star. She lands on Care Senior with the optional NCB Super rider. Premium for Rs 10 lakh sum insured comes to about Rs 51,000. Diabetes declared. PPMC at the Care lab in K.K. Nagar in Madurai. Underwriter loads the premium by ten percent and accepts. The two-year PED waiting period applies to diabetes. Lakshmi self-funds any non-emergency diabetes-related care for two years and treats this as a known cost.
Scenario three. The Chatterjee family, Pune, January 2026. Father sixty-four, hypertensive on amlodipine for twelve years, with a coronary stent placed in 2019 after a non-ST-elevation myocardial infarction. Mother fifty-nine, hypothyroid on levothyroxine. The post-MI father is the difficult underwriting case. Care Supreme declines outright. HDFC Optima Secure declines. Niva Bupa Senior First accepts with a permanent exclusion on cardiac conditions and a two-year PED waiting period on hypertension; this is what most insurers will offer for a profile with documented cardiac event history. The exclusion is meaningful but not catastrophic, since cardiac care under government schemes and through the family's own emergency fund is the fallback. The mother is accepted on a separate individual policy at standard premium. The lesson the family takes from this is that uninsurable does not mean abandon the search; it means accept the terms that match the medical reality and supplement with savings and government coverage.
Scenario four. Suchitra Bhattacharya, GST consultant in Hyderabad, parents in Vellore, February 2026. Father sixty-two with hypertension plus borderline lipid panel, no medication. Mother fifty-eight with osteoarthritis of both knees, no other conditions. HDFC Optima Secure with the ABCD Chronic Care rider is the chosen product because the chosen network in Vellore is heavily HDFC-tied, with CMC Vellore on the cashless list. Suchitra explicitly verifies the network reach in pin code 632004 before signing. Hypertension covered by ABCD from day thirty-one. Cholesterol covered by ABCD from day thirty-one. Osteoarthritis falls under specific-illness waiting at twenty-four months, which Suchitra accepts because the mother is unlikely to need knee replacement in the immediate two-year horizon. The premium loading on the father is minimal. PPMC at the empanelled lab in Vellore. The decision turned on network reach in the specific city, not on aggregate brand reputation.
Scenario five. Sakthivel Murugan, mid-career engineer in Chennai, mother in Karaikudi, March 2026. Mother sixty-eight, diabetic for fifteen years, hypertensive for ten, mild diabetic retinopathy diagnosed 2024. Sakthivel's first instinct is to look at the standard parent-targeted senior plans. The 2024 IRDAI rule that removed the entry-age cap means the mother is technically eligible for any product, but in practice every insurer treats sixty-eight with two long-standing chronic conditions as a high-risk underwriting case. Three insurers decline. Niva Bupa Senior First accepts at a heavily loaded premium of Rs 84,000 for Rs 7.5 lakh sum insured, with a permanent exclusion on diabetic retinopathy and a thirty-percent co-payment on every claim. Sakthivel evaluates whether the policy is worth it. The realistic non-cardiac claim he is insuring against is an infection-related hospitalisation costing two to three lakh rupees, against which the policy minus the co-payment would pay roughly 70 percent, or about Rs 1.4 to Rs 2.1 lakh. He concludes that the policy is worth it as a financial buffer even with the exclusion and co-pay. The lesson is that for older entry-age parents with multiple long-standing conditions, the right policy is the one that is offered, with whatever loading and exclusions come attached, rather than the ideal policy from the brochure.
Scenario six. Karunya Vasanthi, working-age proposer for her own coverage extending to her seventy-year-old mother, April 2026. Karunya already has an Aditya Birla Activ Health Platinum policy for self and spouse since 2023. She uses the IRDAI portability framework to add her mother as a dependent on a separately rated policy under the same insurer. Continuous coverage credit on her own portion is preserved. The mother's portion starts a fresh thirty-six-month PED waiting period and a fresh sixty-month moratorium clock. The optimisation here is administrative, not financial: a single insurer relationship for the family, a single claim mechanism, and a single point of contact for grievances. Premium efficiency is secondary. The IRDAI portability framework is widely under-used; very few proposers know that adding a dependent to an existing policy preserves their own continuous-coverage credit and is sometimes the simplest path to insuring an older parent.
Common Rejection Reasons Across Parental Senior Claims
Senior-claim rejection patterns repeat. The matrix below captures the patterns I see most often in DM threads, Insurance Ombudsman case summaries, and reader correspondence over the last eighteen months. Most of these are fixable through the grievance process if the policyholder has the right documentation, but each one adds weeks to the settlement timeline.
| Rejection ground | What it actually means and how to address it |
| Non-disclosure of pre-existing condition | Insurer claims the proposer suppressed a material fact at proposal stage. Within the 60-month moratorium, insurer must produce primary documentary evidence under the Mahakali Sujatha standard. After moratorium, only established fraud allows repudiation. Defence: produce the full proposal form, the agent's call recording if available, the lab reports submitted at PPMC, and the post-acceptance underwriter letter showing what was loaded or excluded. |
| PED waiting period not yet complete | Claim filed for a declared PED before the 36-month standard wait or the rider-modified wait expires. Procedurally correct rejection in most cases. Defence is limited to checking whether the rider was in force at the date of admission and whether the rider's reduced wait had elapsed. |
| Specific illness waiting period not complete | Common for cataract, knee replacement, hernia, gallstones. Twenty-four months from policy inception in most policies. Often confused with PED waiting; this applies regardless of whether the condition pre-existed. No rider reduces this. Wait it out or self-fund. |
| Treatment in non-network hospital, cashless not approved | The policy is valid but the hospital is outside the cashless network. Claim is admissible on reimbursement basis with full bills, discharge summary, prescription history, and policy schedule submitted within 30 days of discharge. Process is slower; reimbursement timeline is 30 to 90 days under the IRDAI Master Circular. |
| Excluded condition under proposal-acceptance letter | Insurer issued an exclusion at proposal stage, often for a specific organ or condition. Claim filed against that exclusion is rightly rejected. Defence: review whether the exclusion was disclosed at proposal acceptance, whether it was reflected in the policy schedule, and whether the present condition genuinely falls under the excluded heading. Disputable in some cases at the Insurance Ombudsman. |
| Hospitalisation under 24 hours / day-care exclusion | Some procedures done in under 24 hours are not admissible unless they fall under the policy's listed day-care procedures. The list is in the policy schedule. Care Supreme has a 2-hour hospitalisation provision for select procedures. Most others maintain the 24-hour threshold. |
| Documentation deficiency or KYC mismatch | Most common procedural rejection. Bank account name mismatch with PAN, missing discharge summary, prescription history not attached, original bills not submitted. Fixable with refile. The insurer's claim-processing portal lists the deficient documents in the rejection email. |
How to Actually Buy — The Process
The end-to-end process for a clean parental health insurance purchase, from the day the family decides to buy to the day the policy is in force with no surprises, runs about three to four weeks. The main constraint is the PPMC turnaround and the underwriter's review timeline; the other steps are largely under the family's own control.
Begin with a no-commission advisory call. Ditto Insurance and Beshak.org both run free advisory calls for retail buyers, with no commission incentive on which product is recommended. The thirty-minute conversation covers the parents' medical profile, the family's budget, the city of residence and pin code, the typical hospitals the parents already use, and the PED conditions that need rider coverage. The advisor's recommendation is genuinely based on fit, not on margin. The same conversation with a commission-driven agent would push toward whichever product has the highest first-year payout, which is rarely the right product.
The next step is to pull the policy wording PDFs of the two or three short-listed products from the insurer websites. Read the three sections that matter most: the schedule of waiting periods, the schedule of exclusions, and the rider terms. The brochure will not contain these in full. The wording will. Reading the actual wording takes about an hour per product and is the single most under-done step in retail health insurance buying.
Submit the proposal form with full disclosure, attaching every diagnostic lab report from the past two years for each parent. Diabetes-related: HbA1c, fasting and post-prandial glucose. Cardiac: lipid panel, ECG, 2D-Echo if any. Thyroid: TSH, free T3 and T4. Renal: urea, creatinine, eGFR. The PPMC will run the same battery, but submitting the documents up front speeds underwriting.
Attend the PPMC at the insurer's empanelled lab. The insurer typically nominates two or three labs in the parent's city. The cost is reimbursed at fifty percent or more if the proposal is accepted. The PPMC report goes directly to the underwriter; the proposer can request a copy and should.
Review the proposal acceptance letter when it arrives, before paying the premium. The acceptance letter lists the loading, exclusions, and any underwriter-imposed conditions. If the loading is reasonable and no surprise exclusions appear, pay the premium. If the loading is unreasonable or an exclusion is imposed on a condition that was disclosed but not disclosed as serious, request reconsideration before paying. The premium-payment timer starts the policy clock.
Use the thirty-day free look window to verify everything one more time, against the actual policy document. The discipline is the same as in section eight: open the policy on day one, read it on day five, cross-check on day fifteen, decide by day twenty-five. Most of the time, the policy is in order. When it is not, the free-look window is the only effective remedy.
Set a calendar reminder for thirty days before the renewal date in year one. The IRDAI portability framework requires forty-five days of notice for porting to a different insurer; missing that window forfeits the year of accumulated PED waiting credit. Renewing with the same insurer is automatic; porting requires planning.
Frequently Asked Questions
Should I buy a senior-specific health insurance plan or a regular plan with the parents added as a separate policy?
For most parental profiles below age sixty-five with manageable PEDs, a regular comprehensive plan like Care Supreme or HDFC Optima Secure on a separate individual or multi-individual variant produces a better outcome than a senior-specific plan. The senior-specific plans typically carry mandatory co-payments of twenty to thirty percent on every claim, lower sum-insured caps, and tighter sub-limits. They make sense only when the regular plan declines the proposer at the underwriting stage. Run the regular-plan proposal first; if accepted, take it. If declined, then consider the senior-specific plans as the second option.
If I buy in the parent's name, can I claim Section 80D in my own ITR?
Yes, provided you are paying the premium in non-cash mode and from your own bank account. Section 80D allows the deduction for premiums paid by the taxpayer for the health insurance of parents, regardless of whether the parents are dependent. The senior-citizen-parent component allows up to Rs 50,000 in FY 2025-26 under the old tax regime. The deduction is not available under the new regime under Section 115BAC. The policy can be in the parent's name with the taxpayer as the proposer and premium-payer.
My parent has been diagnosed with a condition only weeks before the proposal. Should I delay the proposal until the condition stabilises?
No. Delaying the proposal does not reset the IRDAI 36-month PED look-back window in your favour, because the look-back runs from the policy commencement date, not from the diagnosis date. Delaying merely postpones the start of the moratorium clock, the rider eligibility, and the PED waiting period. Disclose the recent diagnosis fully, attach the diagnostic reports, and let the underwriter make its decision. Recent diagnosis with full disclosure is far less risky than delayed proposal with concealment.
The Care Supreme PED Wait Period Modification rider can be removed after three years. Should I plan to remove it?
The contractual ability to remove a rider after a defined period is one question; the practical wisdom of doing so is another. After thirty-six months of policy commencement, the standard PED waiting period for all declared conditions has lapsed under the base policy. The rider's continuing benefit becomes negligible at that point for the originally declared PEDs. New diagnoses post-policy are not subject to the PED waiting period in any event, regardless of the rider. So the rider's removal at year three is largely a question of premium savings versus the small buffer it offers against borderline cases. For most parental profiles, dropping the rider at year three is a reasonable financial decision; keeping it is a small insurance against narrow edge cases.
What is the IRDAI 60-month moratorium and how does it differ from Section 45?
The IRDAI moratorium is the consumer-protection clause introduced through the Master Circular on Health Insurance Business of 29 May 2024. After sixty months of continuous coverage, the insurer cannot deny a claim on grounds of non-disclosure or misrepresentation, except where established fraud is proven. Continuous coverage includes ported and migrated periods. Section 45 of the Insurance Act 1938 is a separate provision that grants a three-year incontestability window to life insurance policies. The Supreme Court has held that Section 45 does not apply to mediclaim contracts. The IRDAI moratorium is therefore the relevant protection for health insurance, and the timeline is sixty months of continuous coverage rather than three years from issue.
Can the insurer increase the premium on a senior-citizen policy aggressively at renewal?
The IRDAI circular dated 30 January 2025 caps premium increases on senior-citizen health policies at ten percent per annum without prior IRDAI approval. The cap applies at the policy level, not at the individual policyholder level, so insurer-wide product-rate revisions still apply. Insurers must seek prior IRDAI approval before withdrawing senior-citizen-specific products. This caps the worst-case premium-shock outcome but does not eliminate the medical-inflation pressure that drives premium increases broadly across the industry, currently running at around fourteen percent per annum at the underlying claim-cost level.
The HDFC Ergo ABCD rider does not cover hypothyroidism. What are my options for a parent with hypothyroidism?
Three options. First, choose a different product whose PED reduction add-on covers all declared PEDs rather than only the four-condition list, such as Care Supreme with the PED Wait Period Modification at the one-year variant. Second, accept the standard thirty-six-month PED waiting period for hypothyroidism on Optima Secure, which is the easier choice if hypothyroidism is well-controlled and the family is willing to self-fund any thyroid-related care for three years. Third, buy Optima Secure with the ABCD rider for the four covered conditions and supplement with a separate critical illness policy or a separate health-savings buffer for thyroid-related contingencies. The first option is usually the cleanest if the family is choosing between the two products.
How do I verify the network hospital reach in my parent's specific city before signing?
Both Care Health and HDFC Ergo publish hospital-locator tools on their websites, with pin code and city filters. The tool returns the list of cashless network hospitals within a chosen radius. The right verification is to enter the parent's home pin code, set a fifteen-kilometre radius, and check whether the parent's existing physician hospital and the two largest hospitals nearest the home are on the list. Three out of four hits is acceptable. Less than that, and the policy will operate mostly through reimbursement rather than cashless. Aggregator websites also publish the same lists but are sometimes out of date. The insurer's own tool is authoritative.
Aravind's parents now hold a multi-individual Care Supreme policy at Rs 25 lakh sum insured each, with the PED Wait Period Modification rider at the one-year variant. The proposal disclosed every diagnosis, every medication and every prior diagnostic test going back to 2014. The PPMC at the empanelled lab in R.S. Puram in Coimbatore came back clean against the disclosed history. The underwriter loaded the father's premium by seven percent and accepted the mother's at standard rates. Total annual outgo, after the Section 80D deduction at the thirty-percent slab, sits at about Rs 63,000. The thirty-day free-look window passed without surprises. The first renewal will land on a Sunday in May 2027, by which point the originally declared conditions will have completed the rider-modified waiting period and the family will face the small decision of whether to keep the rider or drop it. The moratorium clock starts ticking in May 2031.
What the family did not get, and what no parental health insurance policy can deliver, is certainty. There will be claims that get rejected. There will be hospital bills that exceed the cashless authorisation. There will be conditions that develop in years three and four whose classification, as fresh diagnoses or as belated discoveries of pre-existence, will be contested. The work of the next thirty years for Aravind, and for every adult Indian child managing a senior parent's health insurance, is the work of staying inside the documentation discipline that the proposal began. Pay premiums on time. Disclose every fresh diagnosis at every renewal. Keep policy schedules and acceptance letters in a labelled folder. Update nominations. Track moratorium credit on portability. Read the renewal terms when they arrive, not when a claim is filed. The policy is the easy part. The discipline is the long part. The discipline is also what makes the policy actually pay out when it is needed.
Sources and References
▸ IRDAI Master Circular on Health Insurance Business, IRDAI/HLT/CIR/PRO/84/5/2024, dated 29 May 2024
▸ IRDAI (Insurance Products) Regulations, 2024, gazetted March 2024 and effective 1 April 2024
▸ IRDAI Master Circular on Protection of Policyholders' Interests, 2024
▸ IRDAI free-look period extension notification dated 20 March 2024 (effective 1 April 2024)
▸ IRDAI Senior Citizen Premium Hike Cap Circular dated 30 January 2025
▸ IRDAI Annual Report 2023-24, published December 2024 (irdai.gov.in/document-detail?documentId=6436847)
▸ IRDAI Annual Report 2024-25 highlights via PIB Press Release, late 2025
▸ Council for Insurance Ombudsmen Annual Report 2023-24
▸ IRDAI Order dated 15 December 2025 imposing Rs 1 crore penalty on Care Health Insurance for cashless-claim-settlement lapses
▸ Care Supreme product wording UIN CHIHLIP23128V012223 and brochure (careinsurance.com)
▸ Care Health Insurance Instant Cover and PED Wait Period Modification add-on terms
▸ HDFC Ergo Optima Secure policy wording UIN HDFHLIP23123V022223 (hdfcergo.com)
▸ HDFC Ergo ABCD Chronic Care Rider terms
▸ Section 45 of the Insurance Act, 1938, as amended by the Insurance Laws (Amendment) Act, 2014
▸ Mahakali Sujatha versus Branch Manager, Future Generali India Life Insurance Company, Civil Appeal No. 3821 of 2024, 2024 INSC 296, decided 10 April 2024
▸ Satwant Kaur Sandhu versus New India Assurance Company, (2009) 8 SCC 316
▸ Reliance Life Insurance Co. Ltd. versus Rekhaben Nareshbhai Rathod, (2019) 6 SCC 175
▸ Manmohan Nanda versus United India Insurance Co. Ltd., (2022) 4 SCC 582
▸ Section 80D of the Income-tax Act, 1961, as applicable for FY 2025-26 / AY 2026-27
▸ Insurance Ombudsman Rules, 2017, particularly Rule 13(1)(b)
▸ IRDAI (Health Insurance) Regulations, 2016, particularly Regulation 12 on portability and lifetime renewability
▸ Insurance Regulatory and Development Authority (Protection of Policyholders' Interests, Operations and Allied Matters of Insurers) Regulations, 2024
▸ General Insurance Council Cashless Everywhere initiative dated 24 January 2024
▸ National Health Claims Exchange (NHCX), live since July 2024
▸ Bima Sugam India Federation public website launch dated 17 September 2025
▸ National Commission on Population Technical Group on Population Projections (PIB PRID 1847436)
▸ Press Information Bureau release on Insurance for All, PRID 2254950
▸ Acko India Health Insurance Index 2024 and LocalCircles Health Insurance Premium Survey 2025
▸ Chauhan, Bahuguna, Prinja et al., Cost of hospital services in India, BMC Health Services Research 2022 (CHSI multi-site study)
▸ Insurance Ombudsman complaint volume data summarised by Outlook Money (citing CIO Annual Report 2023-24)
Disclaimer: This article is for educational purposes and does not constitute personalised insurance, legal, tax, financial or investment advice. The opening case of Aravind Subramanian and his parents in Saibaba Colony, Coimbatore, and the six illustrative scenarios in Section 11, are drawn from documented patterns in Insurance Ombudsman case summaries, IRDAI complaint data, payroll-software user-forum discussions, and reader correspondence with this site through October 2025 to April 2026. Names, cities and a few small specifics have been changed. The product references to Care Supreme and HDFC Ergo Optima Secure reflect the policy wordings and add-on terms as published on the respective insurer websites and as last verified on 4 May 2026; readers are urged to verify the current terms directly against the insurer's policy wording PDF before relying on any specific feature, since insurers periodically revise rider terms and waiting-period mechanics through UIN-versioned updates. The IRDAI circular references, gazetted regulations, claim-data figures and Supreme Court judgment citations reflect the position as established in the publicly searchable repositories of IRDAI, the Insurance Ombudsman, the Supreme Court of India and the Press Information Bureau as of 4 May 2026. Where the article notes that a particular feature is in beta, in pending rollout or not yet operational, this reflects what was traceable in publicly accessible sources on the date of writing. Tax positions described are general in nature; the Section 80D limits, the cash-payment exclusion, the preventive-check-up sub-limit, and the new-regime-versus-old-regime applicability are stated as the position under the Income-tax Act 1961 for FY 2025-26 / AY 2026-27. The Mahakali Sujatha principle on insurer burden of proof and the Satwant Kaur Sandhu reading on Section 45 inapplicability to mediclaim contracts are binding precedent but specific case outcomes turn on facts and documentation. Finance Guided is not a SEBI-registered investment advisor, AMFI-registered mutual fund distributor, IRDAI-licensed insurance broker, EPFO-empanelled facilitator, IEPF claim agent, Chartered Accountant in practice, or Advocate, and earns no commission, referral fee or percentage of any insurance policy sale referenced in this article. The recommendation to use no-commission advisors such as Ditto Insurance and Beshak.org reflects the author's view that the absence of commission incentives produces better-fit recommendations for retail buyers. Beware of agents demanding incentive payments to expedite claims; the IRDAI grievance routes via Bima Bharosa and the Council for Insurance Ombudsmen are free.
Dinesh Kumar S
Founder & Author — Finance Guided
B.Sc. Mathematics | M.Sc. Information Technology | Chennai, Tamil Nadu
Dinesh started Finance Guided because most insurance, tax and personal finance content in India is written for professionals, not for the salaried families and young IT workers who actually have to make the decisions. He writes research-based guides verified against IRDAI, SEBI, RBI, EPFO, MoHUA, CBDT, MCA, DoP and Income Tax Department sources. No product sales. No commissions. No paid placements.
0 Comments